The FDA cleared the use of the first approved blood test that can help diagnose Alzheimer’s disease. Learn more from U of U ...

In terms of quality of life, someone 75 years old, retired with significant memory problems, can still have friends and, “a ...

The combination of a recently approved blood test for detection of Alzheimer's disease combined with two medications that slow progression of the disease is drastically improving outcomes for patients ...

A new blood test is being called a game changer for helping diagnose Alzheimer’s, and UNLV helped contribute research to it.

The U.S. Alzheimer's disease diagnostics market, valued at USD 3.53 billion in 2024, is projected to grow at a CAGR of 10.6% ...

Alzheimer’s disease is a type of dementia, and there are more than 7 million Americans living with it. According to the Alzheimer’s Association, 54,500 of them are in Kansas. That comes to about 11% ...

Researchers are investigating blood-based biomarkers like pTau217 for Alzheimer’s detection, offering a less invasive ...

Despite concerns raised by clinicians and ethicists, direct-to-consumer testing for Alzheimer’s disease biomarkers is here, posing new challenges for physician-patient communication.

Test to be available for clinical and research use as soon as this summer, building on Quest's pioneering blood-based AD-Detect™ product line for assessing symptomatic patients SECAUCUS, N.J ...

And I'm wondering, you know, what contribution you have baked in from new tests, you know, things like Haystack, AD Detect, Lumipulse, and then other buckets there, like acquisitions, would really ...